187 related articles for article (PubMed ID: 10901155)
1. Brain noradrenaline and the mechanisms of action of antidepressant drugs.
Svensson TH
Acta Psychiatr Scand Suppl; 2000; 402():18-27. PubMed ID: 10901155
[TBL] [Abstract][Full Text] [Related]
2. Involvement of monoaminergic targets in the antidepressant- and anxiolytic-like effects of the synthetic alkamide riparin IV: Elucidation of further mechanisms through pharmacological, neurochemistry and computational approaches.
Sartori DP; Oliveira NF; Valentim JT; Silva DMA; Mallman ASV; Oliveira ICM; Chaves RC; Capibaribe VC; Carvalho AMR; Rebouças MO; Macedo DS; Chaves Filho AJM; Fonteles MMF; Gutierrez SJC; Barbosa-Filho JM; Mottin M; Andrade CH; Sousa FCF
Behav Brain Res; 2020 Apr; 383():112487. PubMed ID: 31987932
[TBL] [Abstract][Full Text] [Related]
3. Bupropion: a review of its mechanism of antidepressant activity.
Ascher JA; Cole JO; Colin JN; Feighner JP; Ferris RM; Fibiger HC; Golden RN; Martin P; Potter WZ; Richelson E
J Clin Psychiatry; 1995 Sep; 56(9):395-401. PubMed ID: 7665537
[TBL] [Abstract][Full Text] [Related]
4. Do antidepressants possess a common mechanism of action?
Sugrue MF
Biochem Pharmacol; 1983 Jun; 32(12):1811-7. PubMed ID: 6349640
[No Abstract] [Full Text] [Related]
5. Analgesic Mechanisms of Antidepressants for Neuropathic Pain.
Obata H
Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29160850
[TBL] [Abstract][Full Text] [Related]
6. The importance of brain serotonergic receptor mechanisms for the action of antidepressant drugs.
Ogren SO; Fuxe K; Agnati L
Pharmacopsychiatry; 1985 Mar; 18(2):209-13. PubMed ID: 3927330
[TBL] [Abstract][Full Text] [Related]
7. Hypotheses concerning the mechanism of action of antidepressant drugs.
Maj J; Przegalinski E; Mogilnicka E
Rev Physiol Biochem Pharmacol; 1984; 100():1-74. PubMed ID: 6146181
[No Abstract] [Full Text] [Related]
8. [Domino principle--monoamines in bottom-view].
Sümegi A
Neuropsychopharmacol Hung; 2008 Jun; 10(3):131-40. PubMed ID: 18956617
[TBL] [Abstract][Full Text] [Related]
9. Neurochemical aspects of depression: the past and the future?
Jesberger JA; Richardson JS
Int J Neurosci; 1985 Jul; 27(1-2):19-47. PubMed ID: 2991156
[TBL] [Abstract][Full Text] [Related]
10. Galanin receptor antagonists : a potential novel pharmacological treatment for mood disorders.
Ogren SO; Kuteeva E; Hökfelt T; Kehr J
CNS Drugs; 2006; 20(8):633-54. PubMed ID: 16863269
[TBL] [Abstract][Full Text] [Related]
11. Effect of antidepressant agents on beta-adrenergic receptor and neurotransmitter regulatory systems.
Meyerson LR; Ong HH; Martin LL; Ellis DB
Pharmacol Biochem Behav; 1980 Jun; 12(6):943-8. PubMed ID: 6105676
[No Abstract] [Full Text] [Related]
12. [A new concept of antidepressant drugs action: clinical and preclinical data].
Płaźnik A; Kostowski W
Psychiatr Pol; 1994; 28(1):39-50. PubMed ID: 7910691
[TBL] [Abstract][Full Text] [Related]
13. Central pre- and postsynaptic monoamine receptors in antidepressant therapy.
Svensson TH; Dahlöf C; Engberg G; Hallberg H
Acta Psychiatr Scand Suppl; 1981; 290():67-78. PubMed ID: 6939326
[TBL] [Abstract][Full Text] [Related]
14. The pharmacologic profile of fluoxetine.
Stark P; Fuller RW; Wong DT
J Clin Psychiatry; 1985 Mar; 46(3 Pt 2):7-13. PubMed ID: 3871767
[TBL] [Abstract][Full Text] [Related]
15. Role of serotonergic and noradrenergic systems in the pathophysiology of depression and anxiety disorders.
Ressler KJ; Nemeroff CB
Depress Anxiety; 2000; 12 Suppl 1():2-19. PubMed ID: 11098410
[TBL] [Abstract][Full Text] [Related]
16. Molecular and cellular mechanisms of antidepressant drugs.
Owens MJ
Depress Anxiety; 1996-1997; 4(4):153-9. PubMed ID: 9166647
[TBL] [Abstract][Full Text] [Related]
17. Effects of JL 3, a putative antidepressant, on rat noradrenergic and serotonergic systems.
Liégeois J; Seutin V; Scuvée-Moreau J; Dresse A; Bruhwyler J; Géczy J; Delarge J; Damas J
Eur J Pharmacol; 1999 Dec; 386(2-3):211-6. PubMed ID: 10618472
[TBL] [Abstract][Full Text] [Related]
18. Adaptive changes in functions of brain neurotransmitter receptors, evoked by repeated administration of antidepressant drugs.
Przegaliński E
Acta Physiol Pol; 1987; 38(5):373-85. PubMed ID: 2839008
[No Abstract] [Full Text] [Related]
19. [Antidepressive agents: classification and mechanism of action].
Cuenca E; Alamo C; Coullaut-Jáuregui J
Rev Clin Esp; 1997 Nov; 197 Suppl 3():44-7. PubMed ID: 9477690
[No Abstract] [Full Text] [Related]
20. Study of a mechanism responsible for potential antidepressant activity of EMD 386088, a 5-HT6 partial agonist in rats.
Jastrzębska-Więsek M; Siwek A; Partyka A; Antkiewicz-Michaluk L; Michaluk J; Romańska I; Kołaczkowski M; Wesołowska A
Naunyn Schmiedebergs Arch Pharmacol; 2016 Aug; 389(8):839-49. PubMed ID: 27106213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
